logo

For the Inventor, By the Inventor

Hartland, MI, United States of America

Chad A VanHuis

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 57(Granted Patents)


Company Filing History:

goldMedal14 out of 36 
 
Lycera Corporation
 patents
silverMedal5 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 3,381 
 
University of Michigan
 patents
where one patent can have more than one assignee

Years Active: 2017-2021

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 11059796 - Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2021-07-13),
2. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2020-08-18),
3. 10611740 - Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2020-04-07),
4. 10556898 - Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease (2020-02-11),
5. 10442798 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-10-15),
6. 10421751 - Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-09-24),
7. 10364237 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2019-07-30),
8. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2019-03-05),
9. 9932313 - [object Object] (2018-04-03),
10. 9896441 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease (2018-02-20),
11. 9815791 - [object Object] (2017-11-14),
12. 9809561 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2017-11-07),
13. 9783511 - Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease (2017-10-10),
14. 9663502 - 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease (2017-05-30),
15. 9580388 - [object Object] (2017-02-28),

Title: The Innovative Journey of Chad A VanHuis

Introduction: Chad A VanHuis, a talented inventor hailing from Hartland, MI (US), has made significant contributions to the field of innovations with his creative mind and dedication.

Latest Patents: Chad A VanHuis holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to existing problems.

Career Highlights: Throughout his career, Chad A VanHuis has demonstrated a keen eye for identifying gaps in the market and developing groundbreaking inventions to fill those voids. His passion for innovation has led to the creation of several successful products that have improved the lives of many.

Collaborations: Chad A VanHuis has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work effectively in a team and leverage the expertise of others has been instrumental in the success of his projects.

Conclusion: In conclusion, Chad A VanHuis is a visionary inventor whose relentless pursuit of innovation has left a lasting impact on the industry. His dedication to pushing the boundaries of what is possible serves as an inspiration to aspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…